Cholesteryl ester (CE) accumulation in arterial wall macrophages (foam cells) is a prominent feature of atherosclerotic lesions. We have previously shown that murine J774 macrophages, unlike mouse peritoneal macrophages, accumulate large amounts of CE from unmodified low density lipoprotein (LDL). We now report a direct comparison of acyl coenzyme A:cholesterol acyl transferase (ACAT) activity in J774 and mouse peritoneal macrophages. Despite similar chloroquine-inhibitable '25I-LDL degradation in the two macrophages, ACAT activity in LDL-treated J774 macrophages was 10-30-fold higher than that in LDLtreated mouse peritoneal macrophages. In contrast, acetyl-LDL (matched for degradation with LDL) caused marked stimulation of ACAT activity in mouse peritoneal macrophages. From these data we conclude that (a) in the presence of LDL, J774 macrophages have a highly active ACAT cholesterol esterification pathway compared with mouse peritoneal macrophages; and (b) in mouse peritoneal macrophages, there is a marked difference in the ability of acetyl-LDL vs. LDL to stimulate ACAT even when the lipoproteins are matched for degradation.
Introduction
Cholesteryl ester accumulation in arterial wall macrophages (foam cells) is a prominent feature of atherosclerotic lesions (1) (2) (3) . Based primarily on the mouse peritoneal macrophage model, one theory of foam cell formation proposes that macrophages interact not directly with LDL' but rather with a modified form of LDL (e.g., acetyl-LDL) internalized by a distinct, nonregulatable receptor or "scavenger receptor" (4) . The reported inability of mouse peritoneal macrophages to form foam cells in the presence of LDL has not been fully explained but has been thought to be due to a paucity of LDL receptors (5) or to the existence of receptors with a very low affinity for LDL (6) on these cells. 1 . Abbreviations used in this paper: ACAT, acyl coenzyme A:cholesterol acyl transferase; CE, cholesteryl ester; DMEM, Dulbecco's modified Ea- gle's medium; HDL3, high-density lipoprotein3; HMG-CoA, 3-hydroxy-3-methylglutaryl-coenzyme A; LDL, low-density lipoprotein; LPDS, lipoprotein-deficient serum.
As an alternative to this theory, we have been exploring the possibility that foam cells may form by the interaction of native LDL, which has been implicated as the major atherogenic lipoprotein (7) , with macrophages in an altered metabolic state (8, 9) . In particular, we have shown that the J774 macrophage, another murine macrophage, accumulates cholesteryl ester (CE) from native LDL. LDL enters the cell by the apo B,E receptor and is hydrolyzed in lysosomes. The LDL-derived cholesterol is reesterified by acyl coenzyme A:cholesterol acyl transferase (ACAT) (8) . However, the J774 macrophage LDL receptor and 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, the rate-limiting enzyme ofcellular cholesterol biosynthesis, are relatively resistant to down regulation by LDL, resulting in receptor-mediated CE storage (8) . In addition, we recently found that in ACAT-inhibited J774 cells, receptor and reductase down regulation were more complete and cholesterol accumulation did not occur (9) . These data led us to hypothesize that in the basal state in J774 macrophages, LDL-derived cholesterol was diverted away from an intracellular regulatory cholesterol pool by an overactive ACAT cholesterol esterification pathway, leading to diminished down regulation and increased cholesterol esterification (9) .
To further explore this hypothesis, we now compare LDLcholesterol metabolism, with an emphasis on cholesterol esterification by ACAT in foam cell-forming J774 macrophages, with that of mouse peritoneal macrophages, which do not form foam cells in the presence of LDL. This comparison was made possible by the discovery that when mouse peritoneal macrophages are cultured under the appropriate conditions, they express the same degree of LDL receptor activity as J774 macrophages. Thus with equivalent amounts of LDL cholesterol entering the cells, we are able to make a direct comparison of cellular cholesterol metabolism in these two murine macrophages.
Methods
Materials. Dulbecco's modified Eagle's medium (DMEM), penicillin (10, 000 U/ml), streptomycin (10,000 gg/ml), and glutamine (200 mM) U/ml), streptomycin (100 ,ug/ml), and glutamine (292 /g/ml) as described previously (8) . For each experiment, the cells were plated in 16 X 35-mm dishes at a density of 106 cells/dish and then incubated at 370C in an atmosphere containing 8% C02/92% air.
Monolayer cultures of mouse peritoneal macrophages were prepared as previously described (10) . Briefly, peritoneal cells from unstimulated female Swiss Webster mice (25-35 g ) were harvested in phosphate-buffered saline (PBS), collected by centrifugation, and plated on 35-mm dishes (5 X 106 cells from 1.5 mice/dish) in DMEM containing 10% (vol/vol) fetal calf serum and penicillin, streptomycin, and glutamine as above. After 2 h of incubation in the 370C incubator, the monolayers were washed with warm PBS to remove nonadherent cells and then incubated overnight in the 10% fetal calf serum medium unless otherwise indicated.
Lipoproteins. LDL (d, 1.020-1.063 g/ml) and high-density lipoprotein3 (HDL3) (d, 1.125-1.21 g/ml) from fresh human plasma and lipoprotein-deficient serum (LPDS) (d, 1.215 g/ml) from fetal bovine serum were isolated by preparative ultracentrifugation. Acetyl-LDL was prepared by reaction with acetic anhydride as described by Goldstein and coworkers (11) . '25I-labeled LDL and acetyl-LDL were prepared by the iodine monochloride method (12) . LDL labeled with [3H]CE was prepared by incubating [3H]CE-labeled HDL3 (see ref. 13 ; 97% of the radioactivity was present in CE and 3% in free cholesterol) with LDL in the presence of CE transfer protein, purified -400-fold through the carboxymethylcellulose chromatography step as described previously [ 14] ). Specifically, 107 cpm of [3H]CE-labeled HDL3 (1.6 mg CE) plus LDL (16 mg CE) plus CE transfer protein (-' 450 Ag ofthe partially purified protein) were incubated in a total volume of 2 cc for 20 h at 37°C. The labeled LDL was isolated by ultracentrifugation at 1.063 g/ml, dialyzed against 150 mM NaCl, 0.5 mM ethylenediaminetetraacetic acid, pH 7.4, and sterilized by filtration (0.2 AM). The final preparation of [3H]CE-labeled LDL contained 99% of the radioactivity in CE and had a specific activity of 447 cpm/,gg CE.
Lipid mass assays. After incubation in the indicated media, cells were washed and collected as described (8) . After an aliquot was removed for protein determination (15) , the cells were lipid-extracted by the method of Folch et al. (16) . When the cell medium was assayed, lipid extraction was by the method of Bligh and Dyer (17). The lipid extracts were then analyzed for free and total cholesterol content by gas-liquid chromatography (18) . #-sitosterol served as an internal standard to correct for losses during the extraction procedure.
'25I-lipoprotein degradation assay. Monolayers of J774 cells and mouse peritoneal macrophages were preincubated according to the individual figure legends and then incubated for 5 h (unless otherwise noted) at 37°C with the indicated concentrations of '25l-LDL or 1251I acetyl-LDL (100 cpm/ng) alone or with 500 Ag/ml excess ofthe respective unlabeled lipoprotein. The media was then assayed for '251I-lipoprotein degradation as previously described (8) . Specific degradation was calculated by subtracting the nonspecific value (assay in the presence of excess unlabeled lipoprotein) from the total value (assay with '251-lipoprotein alone). 2 Whole cell cholesterol esterification assay. Monolayers of J774 and mouse peritoneal macrophages were preincubated for 20 h in DME/ 10% LPDS and then incubated for 7 h (unless otherwise noted) in DMEM containing 10% LPDS in the absence or presence of added lipoproteins. During the last 2 h of the 7-h incubation, the cells were pulsed at 370C LDL concentrations (2 100 Atg/ml) may be less than the true specific value because the maximal amount of excess unlabeled LDL used in this study was limited to I mg/ml (< 10-fold excess for high '251I-LDL concentrations). Larger amounts of unlabeled LDL could not be used due to cell toxicity.
procedures (12) (5, 11) and as displayed in Fig. 1 (solid bar) . However, when the cells were incubated for 48 h in medium containing LPDS, which has been shown to up-regulate the fibroblast LDL receptor (7), '25I-LDL degradation increased -seven-fold (Fig. 1 ). Both total and specific degradation were inhibited 90% by treatment ofthe cells with 100 uM chloroquine (Table I) , indicating lysosomal hydrolysis of the LDL. Inclusion of butylated hydroxytoluene (20 ,gM) in the incubation of 125I-LDL with LPDS-preincubated mouse peritoneal macrophages did not decrease the amount of lipoprotein degradation, indicating that the augmented degradation of '251I-LDL in these cells was not due to lipoprotein oxidation and subsequent uptake by the scavenger receptor as has been described in other systems (20) . That this up-regulation of LDL receptor activity was related to the incubation with LPDS rather than to the two extra days ofcell culture was demonstrated by showing that mouse peritoneal macrophages incubated for 48 h in medium containing 20% fetal bovine serum instead of LPDS degraded 1251I-LDL only slightly more than fresh mouse peritoneal macrophages (Fig. 1) . Thus, when mouse peritoneal macrophages are preincubated in LPDS-containing medium, the cells acquire the ability to degrade substantial amounts of 125I-LDL.
To directly compare LDL receptor activity in mouse peritoneal and J774 macrophages, cells preincubated in LPDS-containing medium were incubated with increasing amounts of 12511 LDL for 5 h (Fig. 2 A) or with 10 Ag/ml 1251-LDL for increasing time periods (Fig. 2 B) and assayed for total and specific 125I- Monolayers of J774 macrophages (circles) and mouse peritoneal macrophages (triangles) were preincubated for 20 h in 1.5 ml DMEM containing 10% LPDS. The cells were then incubated with 1 ml of DMEM/0. 1% BSA containing either the indicated concentrations of '25I-LDL (± I mg/ml unlabeled LDL) for 5 h (A) or 10 Ag/ml 1251I LDL (± 500 ,g/ml unlabeled LDL) for the indicated time periods (B).
The cells were then assayed for total (solid symbols) and specific2 (open symbols) '251-LDL degradation as described under Methods.
LDL degradation. The 1251-LDL concentration data ( Fig. 2 A) show that specific degradation (open symbols) was similar for both cell types at all concentrations tested.2 Total degradation (solid symbols) was also similar for the two cell types at lower '251-LDL concentrations, and at higher concentrations total degradation was actually greater for mouse peritoneal macrophages (solid triangles) than for J774 macrophages (solid circles). The time course data ( Fig. 2 B) , done at an LDL concentration of 10 ,g/ml, showed similarity of both total and specific '25I-LDL degradation for the two cell types up to at least 6 h ofincubation. Thus, when the two murine macrophages are incubated with similar amounts ofLDL for these time periods, mouse peritoneal macrophages degrade at least as much LDL as J774 macrophages, indicating that at least as much LDL cholesterol reaches the lysosomal compartment ofthe mouse peritoneal macrophage as in the J774 macrophage. CE mass accumulation in LPDS-preincubated J774 and mouse peritoneal macrophages. Because LPDS-preincubated mouse peritoneal macrophages initially (i.e., at least up to 6 h) degrade at least as much LDL as J774 macrophages, we wanted to compare directly the ability of these two cell types to accumulate LDL-derived CE under these conditions. Therefore, LPDS-preincubated mouse peritoneal and J774 macrophages were incubated with increasing amounts of LDL for 24 h and then assayed for cholesterol content (Fig. 3) . At (Fig. 4 A) . Cholesterol esterification in J774 cells was markedly greater than that in mouse peritoneal macrophages in both LPDS-treated cells treated with a wide range of LDL concentrations. In addition, the marked difference in LDL-induced cholesterol esterification in the two cell types was evident when the cells were pulsed with ['4C]oleate after exposure to LDL for different times (Fig. 4 B) . In contrast, incorporation of [14C]oleate into other cellular lipids (Fig. 5) was either similar in the two cell types or actually greater (in the case of phospholipids plus monoglycerides) in the mouse peritoneal macrophages. Thus, the marked differences in cholesterol esterification in the two cell types is not due to an overall difference in cellular lipid fatty acylation. In addition, the data in Fig. 5 imply that the cholesterol esterification differences observed by itself; and (c) to determine the fate in LPDS-preincubated mouse peritoneal macrophages of the internalized LDL-cholesterol that is neither esterified (Fig. 4) nor accumulated as free cholesterol (Fig. 3) (Table III) . As was the case with whole cell cholesterol esterification (Fig. 4) , ACAT activity in microsomes from both LPDS and LDL-treated J774 macrophages was greater than that in microsomes from similarly treated mouse peritoneal macrophages. This was not due to selective loss of mouse peritoneal macrophage enzymatic activity during the microsome isolation procedure, since recovery of the activity in the microsomes compared with that originally in the postnuclear supernate was 99% in mouse peritoneal macrophages and 75% in J774 macrophages; both cell types contained essentially no ACAT activity in the 100,000 g supernate. When (4) . Therefore, we directly compared the ability of acetyl-LDL to stimulate cholesterol esterification in LPDSpreincubated J774 and mouse peritoneal macrophages both as a function of acetyl-LDL concentration (Fig. 6 A) and time of acetyl-LDL incubation (Fig. 6 B) . In sharp contrast to the results with LDL, acetyl-LDL stimulates high levels of cholesterol esterification in mouse peritoneal macrophages as well as J774 macrophages. The data in Table IV treated cells. Thus, despite relatively low levels of both whole cell and microsomal ACAT activity in LPDS and LDL-treated mouse peritoneal macrophages, whole-cell ACAT activity in acetyl-LDL-treated mouse peritoneal macrophages is very high. We next examined ACAT activity in microsomes from acetyl-LDL-treated mouse peritoneal macrophages. The cells were incubated for 5 h with 50 gg/ml acetyl-LDL, and microsomes isolated from these cells were assayed for ACAT activity, which was 1 .78 and 2.49 nmol/mg/ 15 min in the absence and presence of exogenous cholesterol liposomes (200 jg cholesterol/assay), respectively. Thus, although microsomal ACAT activity in acetyl-LDL-treated mouse peritoneal macrophages was substantially higher (approximately four-fold) than that in LDL-treated mouse peritoneal macrophages (see Table III ), the increase was much less than that seen in the whole cell ACAT assay (-40-fold increase in acetyl-LDL vs. LDL-treated cells; see Figs. 4 and 6). In contrast, microsomal ACAT activity in acetyl-LDLtreated J774 macrophages-4.24 and 9.98 nmol/mg/15 min in the absence and presence of cholesterol, respectively-was similar to that in LDL-treated J774 macrophages (see Table III ). This similarity was also seen in whole-cell ACAT activity in LDL and acetyl-LDL-treated J774 macrophages (see Figs. 4 and 6).
Down-regulation of the LDL receptor in mouse peritoneal and J774 macrophages. The marked stimulation of cholesterol esterification by LDL in J774 macrophages is clearly an important property related to the ability of these cells to accumulate CE in the presence of LDL. Another important characteristic of the J774 macrophage that contributes to its ability to accumulate LDL-CE is the diminished down-regulation of its LDL receptor and HMG-CoA reductase (8), and we have demonstrated a relationship between these two important J774 macrophage properties by showing that inhibition of cholesterol esterification leads to increased receptor and reductase down-regulation (9) . We theorized that, in the basal state, J774 macrophages divert LDL cholesterol away from its down-regulatory function into the ACAT pathway and that this diversion is prevented by ACAT inhibition (9) . To further test this relationship, we determined the degree of LDL receptor down-regulation in mouse peritoneal macrophages, cells which in the basal state have very low levels of LDL-induced cholesterol esterification and thus would not be expected to divert regulatory cholesterol. Cells were incubated for 14 h in LPDS-containing medium alone or in the presence of increasing amounts of LDL and then assayed for specific '251-LDL degradation (Fig. 7) . At each preincubation LDL concentration, the mouse peritoneal macrophage receptor is substantially more down-regulated than the J774 receptor. For example, after incubation with 50 ,g/ml LDL, mouse peritoneal macrophage receptor activity is downregulated by 55% whereas the J774 receptor is down-regulated by only 34%. Furthermore, when the cells were preincubated with 50 ug/ml LDL in the presence of the ACAT inhibitor 58-035 (5 ,ug/ml), J774 receptor down-regulation increased to a level (62%) similar to that in the mouse peritoneal macrophage, whereas mouse peritoneal macrophage receptor down-regulation was little changed (58%) by ACAT inhibition. In a related experiment, the LDL receptor of mouse peritoneal macrophages was first up-regulated by an initial incubation with LPDS alone and then subjected to a second incubation with LDL±58-035, and similar results were obtained: 61% down-regulation by LDL (Fig. 2) and LDL-CE hydrolysis (Table II) , indicating similar delivery of LDL-cholesterol to lysosomes, whole cell cholesterol esterification (Fig. 4) and microsomal ACAT (Table III) in LDL-treated J774 and mouse peritoneal macrophages differs markedly. In addition, there is also a difference in the ability of LDL to down-regulate LDL receptor activity in the two cells (Fig. 7) . Thus, in J774 macrophages, as opposed to mouse peritoneal macrophages, LDL cholesterol is markedly more effective at stimulating cholesterol esterification and less effective at causing receptor down-regulation, two properties which help to explain the ability of J774 macrophages to accumulate LDL-derived CE. Conversely, the contrasting fates of LDL-cholesterol in mouse peritoneal macrophages (decreased esterification and increased down-regulation) help to explain the inability of these cells to form foam cells in the presence of LDL. The failure of mouse peritoneal macrophages to accumulate CE from LDL is clearly not due to a simple lack of LDL receptor activity.
We found that J774 macrophages incubated in the absence of lipoproteins have greater whole-cell ACAT activity than similarly treated mouse peritoneal macrophages (Fig. 4) . We also found that isolated microsomes from J774 macrophages demonstrate much greater ACAT activity than microsomes from mouse peritoneal macrophages even when assayed in the presence of saturating amounts of exogenous cholesterol (see Table  III ). These data may suggest that J774 macrophages have a greater amount of the ACAT enzyme. However, it is also possible that neither the whole cell ACAT assay in cells incubated in the ab- (Fig. 2 B) .
Another possibility is related to the observation in other cells that the general mechanism of lipoprotein-induced stimulation of ACAT is related to substrate (i.e., lipoprotein-derived cholesterol) activation (22, 23) and perhaps cholesterol-induced allosteric activation (22) . Thus, one possible interpretation of our data is that J774 and mouse peritoneal macrophages differ in their ability to transfer LDL-derived cholesterol, but not acetyl-LDL-derived cholesterol, to microsomal ACAT. Perhaps LDL and acetyl-LDL, which enter the cell by two distinct receptors (4) , are routed to two different subpopulations of lysosomes (see refs. 24-26 for examples of lysosomal subpopulations) that differ in their ability to transfer cholesterol to microsomal ACAT in the mouse peritoneal macrophage but not in the J774 macrophage. This hypothesis implies that the information directing the ligands to different lysosomal pathways initially resides in the ligand-receptor complex.
The demonstration that J774 macrophages and mouse peritoneal macrophages degrade similar amounts of LDL was necessary to allow us to subsequently compare intracellular lipoprotein-cholesterol metabolism in these two murine macrophages. Freshly isolated mouse peritoneal macrophages have been previously demonstrated to display very low LDL receptor activity (5, 1 1), and thus their inability to accumulate LDLderived CE was thought to be explainable by this finding. However, Mahley et al. (27) have stated that mouse peritoneal macrophage LDL receptors can be up-regulated to a certain degree, and Hammond et al. (6) , using the immunoblot technique with antibodies to the adrenal LDL receptor, have recently demonstrated that mouse peritoneal macrophages possess high levels of the apo B,E receptor. These data, together with our data showing significant '25I-LDL degradation by cells that had been preincubated in LPDS-containing medium (Fig. 1) , indicate that the inability of these cells to accumulate LDL-derived CE is not simply due to a lack of LDL receptors or LDL receptor activity. In this respect, mouse peritoneal macrophages are similar to human monocyte-derived macrophages, which also demonstrate significant LDL receptor activity and yet do not accumulate LDL-derived CE (28, 29) . In fact, we have found that despite the relatively high level of '25I-LDL degradation by human monocyte-derived macrophages, cholesterol esterification in these cells is stimulated very poorly by LDL (at 200 ,g/ml LDL, cholesterol esterification was 0.56 nmol/mg/h) compared to LDL stimulation of cholesterol esterification in J774 cells (7. 56 nmol/ mg/h; see Fig. 4 ). Thus the inability of internalized LDL cholesterol to stimulate cholesterol esterification described in this report for mouse peritoneal macrophages is also found in macrophages derived by tissue culture of human blood monocytes.
Our current findings together with those in our previous reports (8, 9) have helped define the mechanisms whereby J774 macrophages accumulate CE from LDL. The cells poorly downregulate their LDL receptors and HMG-CoA reductase (8) , thus leading to increased cholesterol entry into the cell and synthesis by the cell, and they very efficiently esterify LDL-derived cholesterol (and also, perhaps, endogenous cholesterol). Furthermore, we have demonstrated that ACAT inhibition increases receptor and reductase down-regulation and have suggested that overactive cholesterol esterification by ACAT leads to diversion of LDL-cholesterol away from its regulatory functions (9) . The present report confirms that a high level of ACAT activity is a prominent feature of the J774 macrophage. In addition, J774 macrophages have a relative deficiency in lipoprotein-derived cholesterol excretion in response to LPDS (Table I) . Whether this is a primary characteristic of these cells or secondary to diversion of LDL-cholesterol by overactive ACAT (or possibly secondary to underactive CE hydrolysis) has yet to be determined. These important properties of J774 macrophages that lead to their ability to accumulate LDL-derived CE are not simply due to the fact that these macrophages are a continuous cell line, because two other macrophage cell lines-the murine P388D1 line and the human HL60 line-do not accumulate LDL-derived CE (8) . Whether or not one or all of the J774 properties can be experimentally induced in macrophage models that do not form foam cells with LDL (e.g., the mouse peritoneal macrophage or the human monocyte-derived macrophage) and whether or not actual atheroma foam cells possess these properties is yet to be determined.
